₹638.45-29.65 (-4.44%)
04:01 PM, 30-Dec-2024₹645.20-23.20 (-3.47%)
03:53 PM, 30-Dec-2024BSE : 544222
NSE : AKUMS
Sector : Health care
ISIN Code : INE09XN01023
Last Updated: 30-Dec-2024 | 09:31 PM IST
Market Cap (₹ Cr.) | 10,049 |
Traded Value (₹ Cr) | 3.07 |
Volume (Shares) | 48,122 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,174.85 |
52-Week High Date | 20-Aug-2024 |
52-Week Low (₹) | 527.00 |
52-Week Low Date | 19-Nov-2024 |
All Time High (₹) | 1,174.85 |
All Time High Date | 20-Aug-2024 |
All Time Low (₹) | 527.00 |
All Time Low Date | 19-Nov-2024 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr.) | 10,155 |
EPS - TTM (₹) [C] | 17.41 |
P/E Ratio (X) [C] | 37.06 |
Face Value (₹) | 2 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [C] | 180.08 |
P/B Ratio (₹) [C] | 3.58 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
SBI Conservative Hybrid Fund - (G) | 28.17 | 4,78,032 | 0.28 |
SBI Conservative Hybrid Fund - (IDCW-M) | 28.17 | 4,78,032 | 0.28 |
SBI Conservative Hybrid Fund - (IDCW-Q) | 28.17 | 4,78,032 | 0.28 |
SBI Conservative Hybrid Fund - (IDCW-A) | 28.17 | 4,78,032 | 0.28 |
SBI Conservative Hybrid Fund - Direct (G) | 28.17 | 4,78,032 | 0.28 |
SBI Conservative Hybrid Fund - Direct (IDCW-A) | 28.17 | 4,78,032 | 0.28 |
SBI Conservative Hybrid Fund - Direct (IDCW-M) | 28.17 | 4,78,032 | 0.28 |
SBI Conservative Hybrid Fund - Direct (IDCW-Q) | 28.17 | 4,78,032 | 0.28 |
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 632.40 678.40 |
Week Low/High (₹) | 555.60 678.40 |
Month Low/High (₹) | 552.35 678.40 |
Year Low/High (₹) | 530.05 1,176.00 |
All time Low/High (₹) | 527.00 1,176.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 7.90% | 7.91% | -0.37 | -0.46% |
1 Month | 6.57% | 6.63% | -1.95 | -2.01% |
3 Month | -22.86% | -22.81% | -7.18 | -8.39% |
6 Month | % | % | -0.99 | -1.52% |
1 Year | % | % | 8.32 | 8.81% |
3 Year | % | % | 35.39 | 37.44% |
Managing Director : SANDEEP JAIN
Managing Director : SANJEEV JAIN
Independent Director : Matangi Gowrishankar
Company Sec. & Compli. Officer : Dharamvir Malik
Independent Director : Kewal Kundanlal Handa
Independent Director : NAND LAL KALRA
Whole-time Director : Sanjay Sinha
Non Executive Director : SUNIL KUMAR THAKUR
Independent Director : SATWINDER SINGH
Registered Office: 304 Mohan Place LSC Saraswati, Vihar,Delhi,Delhi-110034 Ph: +91 11 6904 1000
Email:cs@akums.net
1. What's the Akums Drugs & Pharmaceuticals Ltd share price today?
Akums Drugs & Pharmaceuticals Ltd share price was Rs 638.45 at 04:01 PM IST on 30th Dec 2024. Akums Drugs & Pharmaceuticals Ltd share price was down by 4.44% from the previous closing price of Rs 668.10. Akums Drugs & Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Akums Drugs & Pharmaceuticals Ltd stock?
The performance of the Akums Drugs & Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Akums Drugs & Pharmaceuticals Ltd?
Akums Drugs & Pharmaceuticals Ltd has a market capitalisation of Rs 10,049 crore.
4. What is Akums Drugs & Pharmaceuticals Ltd's 52-week high/low share price?
The Akums Drugs & Pharmaceuticals Ltd’s 52-week high share price is Rs 1,174.85 and 52-week low share price is Rs 527.00.
5. Is the Akums Drugs & Pharmaceuticals Ltd profitable?
On a consolidated basis, Akums Drugs & Pharmaceuticals Ltd reported a profit of Rs 50.37 crore on a total income of Rs 360.47 crore for the quarter ended 2024. For the year ended Sep 2024, Akums Drugs & Pharmaceuticals Ltd had posted a profit of Rs 66.65 crore on a total income of Rs 1,050.26 crore.
6. Which are Akums Drugs & Pharmaceuticals Ltd’s peers in the Health care sector?
Akums Drugs & Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Marksans Pharma, Glenmark Life, Sanofi Consumer, Akums Drugs, Blue Jet Health, Orchid Pharma, Ami Organics.
7. Who owns how much in Akums Drugs & Pharmaceuticals Ltd?
Key changes to the Akums Drugs & Pharmaceuticals Ltd shareholding are as follows: